A rare CYP19 (aromatase) variant may increase the risk of breast cancer

Pharmacogenetics

Volumn 8, Issue 1, 1998, Pages 43-48

  Kristensen, Vessela Nedelcheva ^a   Andersen, Tone Ikdahl ^a,b   Lindblom, Annika ^c   Erikstein, Bjoørn ^a   Magnus, Per ^d   Børresen Dale, Anne Lise ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Allele frequency; Aromatase; Bis benzimide; Breast cancer; CYP19; Tetranucleotide repeat

Indexed keywords

AROMATASE; CYTOCHROME P450; ESTROGEN RECEPTOR; MESSENGER RNA; NUCLEOTIDE; PROGESTERONE RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE DETECTION; HUMAN; HUMAN CELL; INTRON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; AROMATASE; BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE FREQUENCY; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; ODDS RATIO; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; VARIATION (GENETICS);

EID: 0013689839     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199802000-00006     Document Type: Article

References (26)

1. Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K, Børresen A-L. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 1994; 94, 665-670.
2. Andersen TI, Eiken HG, Couch F, Kaada G, Skrede M, Johnsen H, Aloysius TA, Tveit KM, Tranebjærg L, Dørum A et al. Constant denaturing gel electrophoresis (CDGE) in BRCA1 mutation screening. Hum Mutation 1997; in press.
3. Bulun SE, Economos K, Miller D, Simpson ER. CYP19 (Aromatase cytochrome P450) gene expression in human malignant endometrial tumors. J Clin Endocrinol Metabol 1994; 79, 1831-1834.
4. Chu C-S, Trapnell BC, Curristin S, Cutting GR, Crystal RG. Genetic basis of various exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nature Genet 1993; 3, 151-156.
5. Evans CT, Corbin CJ, Saunders CT, Merril JC, Simpson ER, Mendelson CR. Regulation of estrogen biosynthesis in human adipose stromal cells: effects of dibutyryl cyclic AMP. epidermal growth factor, and phorbol esters on the synthesis of aromatase cytochrome P450. J Biol Chem 1987; 262, 6914-6920.
6. n microsatellites. Hum Gen 1996; 98, 616-619.
7. Harada N, Utsumi T, Takagi Y. Tissue specific expression of the human aromatase cytochrome P450 gene by alternative use of multiple exons and promoters, and switching of tissue specific exons 1 in carcinogenesis. Proc Natl Acad Sci USA 1993; 90, 11312-11316.
8. Harada N, Utsumi T, Takagi Y. Molecular and epidemiological analyses of abnormal expression of aromatase in breast cancer. Pharmacogenetics 1995; 5, S59-S64.
9. Hsu CJ, Kirkman BR, Fishman J. Differential expression of oncogenes c-fos, c-myc and Her-2/neu induced by estradiol and 16α hydroxyestrone in human breast cancer cell line and the progesterone receptor. J Steroid Biochem 1991; 87, 184-190.
10. Kasid D, Lipman L. Regulation of growth factors by estrogen through the estrogen receptor. J Steroid Biochem 1987; 27, 465-470.
11. Mahendroo MS, Mendelson CR, Simpson ER. Tissue specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem 1993; 268, 19463-19470.
12. Matheson I, Tretli S. Changes in breast cancer incidence among Norwegian women under 50. Lancet 1996; 348, 900-901.
13. Means GD, Mahendroo MS, Corbin CJ, Mathis JM, Powell FE, Mendelson CR, Simpson ER. Structural analysis of the gene encoding human aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. J Biol Chem 1989; 264, 19386-19391,.
14. Muller W, Hattesohl I, Schuetz HJ, Meyer G. Polyethyleneglycol derivatives of base and sequence specific DNA ligands: DNA interaction and application for base specific seperation of DNA fragments by gel electrophoresis. Nucleic Acid Research 1981; 9, 95-117
15. Nedelcheva V, Børresen-Dale AL. Improved electrophoretic separation of polymorphic short tandem repeats in agarose gels using bis-benzimide. BioTechniques 1997; in press.
16. Pike MC, Spicer DV, Dagmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev 1993; 15, 17-35.
17. Pink JJ, Jordan VC. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 1996; 56, 2321-2330.
18. Polymeropulous MH, Xiaoh H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human aromatase cytochrome p 450 gene (CYP19). Nucl Acids Res 1991; 19, 195.
19. Sadekova SI, Tan L, Chow TY-K. Identification of the Aromatase in the breast carcinoma cell lines T47D and MCF-7. Anticancer Res 1994; 14, 507-512.
20. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 1994; 25, 530-535.
21. Sasano H, Kaga K, Sato S, Yajima A, Nagura H, Harada N. Aromatase gene cytochrome P450 gene expression in endometrial carcinoma. Br J Cancer 1996; 74, 1541-1544.
22. Simpson ER, Mahendroo MS, Nichols JE, Bulun SE. Aromatase gene expression in adipose tissue. Int J Fertil 1994; 39, 75-83.
23. Spillman MA, Bowcock AM. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene 1996; 13, 1639-1645.
24. Wolf MS, Toniolo PG. Environmental organochlorine exposures as a potential etiological factor in breast cancer. Environ Health Perspect 1995; 103, 141-145.
25. Wooster R, Cleton-Jansen AM, Collins N, Mangion J, Cornelis RS, Cooper CS, Gustersun BA, Ponder BJA, von Deimling A, Wiestler OD et al. Instability of short tandem repeats (microsatellites) in human cancers. Nature Gen 1994; 6, 152-156.
26. Zhang L, Leeflang EP, Yu J, Arnheim N. Studying human mutations by sperm typing: instability of CAG trinucleotide repeats in the human androgen receptor gene. Nature Gen 1994; 7, 531-535.